Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Profound Medical Corp (PROF)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 7

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

Market reaction Comment Full text

Masimo Corporation (MASI)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 6

Masimo - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

Market reaction Comment Full text

CervoMed Inc (CRVO)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 6

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

Market reaction Comment Full text

Spectral AI (MDAIW)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 6

DeepView® System highlighted at the annual British Burn Association conference

Market reaction Comment Full text

Evolus Inc (EOLS)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 6

Evolus - Evolysse™ Recognized in 2025 Shape Skin Awards

Market reaction Comment Full text

Brainsway Ltd (BWAY)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 6

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Market reaction Comment Full text

QuantumSi Inc (QSIAW)

  • Business News
  • June 10, 2025, 12:00 UTC
  • 7

Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay

Market reaction Comment Full text

Cytokinetics Inc (CYTK)

  • Business News
  • June 10, 2025, 11:30 UTC
  • 6

Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program

Market reaction Comment Full text

Genmab (GMAB)

  • Business News
  • June 10, 2025, 11:24 UTC
  • 5

Transactions in Connection with Share Buy-back Program

Market reaction Comment Full text

Evogene Ltd (EVGN)

  • Business News
  • June 10, 2025, 11:13 UTC
  • 3

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

Market reaction Comment Full text
  • Previous
  • 116
  • 117
  • 118
  • 119
  • 120
  • Next

Search

News categories

  • Technical Exchange News(9387)
  • Event(407)
  • SEC News(153541)
  • FDA Approval(8758)
  • Company Report(721)
  • Business News(104676)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin